France Diagnostic Enzymes Market Size & Outlook, 2026-2033
- Clinical Diagnostics
- Reagents & Assays
- Diagnostic Enzymes Market Outlook
- Reagents & Assays
Global Market
Related Markets
Ask a question about the diagnostic enzymes market
France diagnostic enzymes market highlights
- The France diagnostic enzymes market generated a revenue of USD 245.0 million in 2025 and is expected to reach USD 452.9 million by 2033.
- The France market is expected to grow at a CAGR of 8.1% from 2026 to 2033.
- In terms of segment, glucose oxidase/glucose dehydrogenase was the largest revenue generating type in 2025.
- Lactate dehydrogenase is the most lucrative type segment registering the fastest growth during the forecast period.
Diagnostic enzymes market data book summary
| Market revenue in 2025 | USD 245.0 million |
| Market revenue in 2033 | USD 452.9 million |
| Growth rate | 8.1% (CAGR from 2026 to 2033) |
| Largest segment | Glucose oxidase/glucose dehydrogenase |
| Fastest growing segment | Lactate dehydrogenase |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Taq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase |
| Key market players worldwide | Takara Bio Inc, Promega, Enzo Biochem Inc, Merck KGaA, Thermo Fisher Scientific Inc, Roche, Roche Holding AG ADR, Solis BioDyne, Ampliqon, Yashraj Biotechnology |
Other key industry trends
- In terms of revenue, France accounted for 4.5% of the global diagnostic enzymes market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany diagnostic enzymes market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 555.2 million by 2033.
The France diagnostic enzymes market is projected to grow at a lucrative rate during the forecast period, owing to high cancer prevalence and increasing burden of chronic diseases. According to the European Cancer Inequalities Registry, in 2023, France is estimated to have diagnosed over 433,000 new cancer cases, making cancer the leading cause of premature mortality in the country.
Furthermore, after cancer, heart attacks are France's second-leading cause of mortality. Emergency services are to be alerted as soon as feasible if someone appears to be experiencing a heart attack so that a diagnosis and, if necessary, treatment can be given as soon as possible. This further propels the need to provide better diagnostic techniques using enzymes for the detection of the condition and providing accurate treatment options.
No credit card required*
Publish Date: Sep 18, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diagnostic Enzymes Market Scope
Diagnostic Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | www.roche.com |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | www.promega.com/es |
| Enzo Biochem Inc | View profile | 190 | 527 Madison Avenue, New York, NY, United States, 10022 | www.enzo.com |
| Solis BioDyne | View profile | 51-100 | Tartu, Tartumaa, Estonia, Europe | solisbiodyne.com |
| Ampliqon | View profile | 11-50 | Odense, Syddanmark, Denmark, Europe | www.ampliqon.com |
| Yashraj Biotechnology | View profile | 251-500 | Mumbai, Maharashtra, India, Asia | www.yashraj.com |
France Diagnostic Enzymes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Diagnostic Enzymes Market Outlook will help companies and investors design strategic landscapes.
Glucose Oxidase/Glucose Dehydrogenase was the largest segment with a revenue share of 9.31% in 2025.
Horizon Databook has segmented the France diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase covering the revenue growth of each sub-segment from 2021 to 2033.
The France diagnostic enzymes market is projected to grow at a lucrative rate during the forecast period, owing to high cancer prevalence and increasing burden of chronic diseases. According to the European Cancer Inequalities Registry, in 2023, France is estimated to have diagnosed over 433,000 new cancer cases, making cancer the leading cause of premature mortality in the country.
Furthermore, after cancer, heart attacks are France's second-leading cause of mortality. Emergency services are to be alerted as soon as feasible if someone appears to be experiencing a heart attack so that a diagnosis and, if necessary, treatment can be given as soon as possible. This further propels the need to provide better diagnostic techniques using enzymes for the detection of the condition and providing accurate treatment options.
- France Diagnostic Enzymes Market Type Outlook (Revenue, USD Million , 2021-2033)
- UNG
- RNase inhibitor
- PCR Master Mix
- Acid phosphatase
- Alanine aminotransferase
- Angiotensin converting enzyme
- Gamma glutamyl transferase
- Renin
- Taq polymerase
- MMLV RT
- T7 RNA polymerase
- Cas9 enzyme
- Alkaline phosphatase
- Lactate dehydrogenase
- Glutamate oxidase
- HIV RT
- Hot start Taq pol
- Lyophilised Polymerase
- Glucose oxidase/glucose dehydrogenase
- Others
- Bst polymerase (LAMP enzyme)
- Amylase
- Aspartate aminotransferase
- Cholinesterase
- Creatinine kinase
- Urease
- Lactate oxidase
- Horseradish peroxidase
- France Diagnostic Enzymes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Diabetes
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Others
- Cardiology
- Nephrology
- France Diagnostic Enzymes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Molecular Enzymes
- Clinical Enzymes
- France Diagnostic Enzymes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinical Laboratories
- Other End Users
Reasons to subscribe to Diagnostic Enzymes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Diagnostic Enzymes Market Outlook databook
- Our clientele includes a mix of Diagnostic Enzymes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Diagnostic Enzymes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Diagnostic Enzymes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
France Diagnostic Enzymes Market, 2021-2033 (US$M)
France diagnostic enzymes market statistics, by type, 2021-2033 (US$M)
